Sino Biopharm (SBP Group) Cancels 40.35 Million Shares, Issued Capital Drops 0.22%

Bulletin Express06-04 16:48

On 4 June 2026, Sino Biopharmaceutical Limited (abbreviated as Sino Biopharm or SBP Group) reported the formal cancellation of 40.35 million previously repurchased ordinary shares.

Prior to the cancellation, the company had 18.75 billion issued shares outstanding. Following the reduction, the share count fell to 18.71 billion, marking a 0.22% contraction in issued capital.

The cancelled shares were repurchased between 21 April and 22 May 2026 at a volume-weighted average price of HKD 5.471 per share. Based on this price, the aggregate consideration for the repurchased shares amounts to approximately HKD 220.75 million.

No treasury shares remain on the balance sheet, and there are no additional redeemed or repurchased shares pending cancellation as of the reporting date.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1146831238?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-04 16:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1146831238","market":"us","top_or_hot":-1,"title":"Sino Biopharm (SBP Group) Cancels 40.35 Million Shares, Issued Capital Drops 0.22%","media":"Bulletin Express","content":"<p>On 4 June 2026, Sino Biopharmaceutical Limited (abbreviated as Sino Biopharm or SBP Group) reported the formal cancellation of 40.35 million previously repurchased ordinary shares.</p>\n<p>Prior to the cancellation, the company had 18.75 billion issued shares outstanding. Following the reduction, the share count fell to 18.71 billion, marking a 0.22% contraction in issued capital.</p>\n<p>The cancelled shares were repurchased between 21 April and 22 May 2026 at a volume-weighted average price of HKD 5.471 per share. Based on this price, the aggregate consideration for the repurchased shares amounts to approximately HKD 220.75 million.</p>\n<p>No treasury shares remain on the balance sheet, and there are no additional redeemed or repurchased shares pending cancellation as of the reporting date.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sino Biopharm (SBP Group) Cancels 40.35 Million Shares, Issued Capital Drops 0.22%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSino Biopharm (SBP Group) Cancels 40.35 Million Shares, Issued Capital Drops 0.22%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-04 16:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On 4 June 2026, Sino Biopharmaceutical Limited (abbreviated as Sino Biopharm or SBP Group) reported the formal cancellation of 40.35 million previously repurchased ordinary shares.</p>\n<p>Prior to the cancellation, the company had 18.75 billion issued shares outstanding. Following the reduction, the share count fell to 18.71 billion, marking a 0.22% contraction in issued capital.</p>\n<p>The cancelled shares were repurchased between 21 April and 22 May 2026 at a volume-weighted average price of HKD 5.471 per share. Based on this price, the aggregate consideration for the repurchased shares amounts to approximately HKD 220.75 million.</p>\n<p>No treasury shares remain on the balance sheet, and there are no additional redeemed or repurchased shares pending cancellation as of the reporting date.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01177","symbol_name":"中国生物制药","start_time":0,"source_url":"","article_id":"1146831238","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1146831238","pubTimestamp":1780562898,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"On 4 June 2026, Sino Biopharmaceutical Limited (abbreviated as Sino Biopharm or SBP Group) reported the formal cancellation of 40.35 million previously repurchased ordinary shares. Prior to the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01177":"中国生物制药"},"translate_title":"中国生物制药(SBP Group)注销4035万股已发行股本下降0.22%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01177":1},"content_text":"On 4 June 2026, Sino Biopharmaceutical Limited (abbreviated as Sino Biopharm or SBP Group) reported the formal cancellation of 40.35 million previously repurchased ordinary shares.\nPrior to the cancellation, the company had 18.75 billion issued shares outstanding. Following the reduction, the share count fell to 18.71 billion, marking a 0.22% contraction in issued capital.\nThe cancelled shares were repurchased between 21 April and 22 May 2026 at a volume-weighted average price of HKD 5.471 per share. Based on this price, the aggregate consideration for the repurchased shares amounts to approximately HKD 220.75 million.\nNo treasury shares remain on the balance sheet, and there are no additional redeemed or repurchased shares pending cancellation as of the reporting date.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1146831238","isCrawlerRequest":true}